NDC 78206-173

SINGULAIR

Montelukast Sodium

SINGULAIR is a Oral Tablet, Chewable in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is Montelukast Sodium.

Product ID78206-173_44fce13e-2484-4ea6-9995-2e2b68331c29
NDC78206-173
Product TypeHuman Prescription Drug
Proprietary NameSINGULAIR
Generic NameMontelukast Sodium
Dosage FormTablet, Chewable
Route of AdministrationORAL
Marketing Start Date2021-06-01
Marketing CategoryNDA /
Application NumberNDA020830
Labeler NameOrganon LLC
Substance NameMONTELUKAST SODIUM
Active Ingredient Strength5 mg/1
Pharm ClassesLeukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 78206-173-01

30 TABLET, CHEWABLE in 1 BOTTLE (78206-173-01)
Marketing Start Date2021-06-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "SINGULAIR" or generic name "Montelukast Sodium"

NDCBrand NameGeneric Name
0006-1711SINGULAIRmontelukast sodium
0006-3841SINGULAIRmontelukast sodium
0006-9117SINGULAIRmontelukast sodium
0006-9275SINGULAIRmontelukast sodium
68258-3033SINGULAIRSINGULAIR
68258-3032SINGULAIRSINGULAIR
21695-221SINGULAIRSINGULAIR
21695-565SINGULAIRSINGULAIR
63629-2979SINGULAIRSINGULAIR
63629-3701SINGULAIRSINGULAIR
0054-0259Montelukast SodiumMontelukast Sodium
0054-0288Montelukast SodiumMontelukast Sodium
0054-0289Montelukast SodiumMontelukast Sodium
0093-7424Montelukast SodiumMontelukast Sodium
0093-7425Montelukast SodiumMontelukast Sodium

Trademark Results [SINGULAIR]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SINGULAIR
SINGULAIR
74589438 2048127 Live/Registered
MERCK SHARP & DOHME CORP.
1994-10-24
SINGULAIR
SINGULAIR
73793956 1570791 Live/Registered
NORWALK WASTEWATER EQUIPMENT COMPANY
1989-04-17

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.